Catalyst Wire Dossier Catalyst Wire Dossier

Lentiviral gene therapy for X-linked chronic granulomatous disease

· Great Ormond Street Hospital for Children NHS Foundation Trust
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lentiviral gene therapy for X-linked chronic granulomatous disease, covering 2012-06-04 to 2012-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD) [Phase 1, Phase 2]

See pricing